VER-01 Expands cannabis-derived medicines Options
Erin J. Walsh explains how VER-01 could position cannabis-derived medicines in chronic pain care, urging standardized pharmaceutical testing and further
Tag: clinical trials
Vertanical launches medical cannabis Exilby in Europe
medical cannabis Exilby launches in Germany and Austria after EU approval for chronic low back pain. FDA Breakthrough granted; US Phase 3 trial of 810
DOJ Filing Challenges cannabis rescheduling
MMJ International rejects DOJ filing on cannabis rescheduling, saying it undercuts FDA approvals, workplace drug testing and compliant clinical trials.
Oxford Cannabinoid Advances cannabis research in UK
Oxford Cannabinoid Technologies advances cannabis research in the UK focusing on clinical pipelines, MHRA approvals and consolidation among domestic
Germany Approves cannabis painkiller Exilby for Back Pain
cannabis painkiller Exilby wins German approval for chronic back pain; phase‑3 showed 1.9 vs 1.4 pain reduction, 17% discontinued; launch planned Sept 2026.
Study shows cannabis improves PTSD symptoms long-term
A recent study published in the journal Expert Review of Neurotherapeutics highlights the long-term benefits of cannabis for patients with…
UK study shows cannabis improves outcomes in epilepsy patients
A recent study from the UK highlights the benefits of cannabis-based medicines for patients suffering from treatment-resistant epilepsy. Utilizing data…